Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-015829

Chief Scientific Officer acquired 76,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Monahan Joseph Chief Scientific Officer 2022-03-01 Option exercise +13,750 101,051 D
Monahan Joseph Chief Scientific Officer 2022-03-01 Option exercise +50,000 151,051 D
Monahan Joseph Chief Scientific Officer 2022-03-02 Option exercise +12,500 163,551 D
Derivatives
Monahan Joseph Chief Scientific Officer 2022-03-01 Grant or award · Employee Stock Option (Right to Buy) +153,100 153,100 D
Monahan Joseph Chief Scientific Officer 2022-03-01 Grant or award · Restricted stock units +43,700 43,700 D
Monahan Joseph Chief Scientific Officer 2022-03-01 Option exercise · Restricted stock units −13,750 13,750 D
Monahan Joseph Chief Scientific Officer 2022-03-01 Option exercise · Restricted stock units −50,000 150,000 D
Monahan Joseph Chief Scientific Officer 2022-03-02 Option exercise · Restricted stock units −12,500 25,000 D
Loading xslF345X03/doc4.xml…